anti-oestrogen
These findings indicate that combined       treatment with anti-HER2 antibody and anti-oestrogen may be useful for the       treatment of patients with breast cancer expressing both ER and HER2.
These findings indicate that combined       treatment with anti-HER2 antibody and  @SUBJECT$  may be useful for the        @PREDICAT$  of  @OBJECT$  with breast cancer expressing both ER and HER2.